WMS Partners’s Acorda Therapeutics ACOR Stock Holding History

WMS Partners’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-44	Closed	-$202K	–	251
2014 Q1	$202K	Buy	+44	New	+$178K	0.03%	233

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

WMS Partners's ACOR Position: Q2 2014 in Review

WMS Partners sold out of Acorda Therapeutics (ACOR) in Q2 2014, closing a stake of 44 shares — an estimated $202K sold.

WMS Partners first reported a position in ACOR in Q1 2014 and held it in 1 quarter. The position peaked at $202K in Q1 2014. 162 funds tracked by Wall St. Rank hold ACOR as of Q2 2014.

WMS Partners reported no remaining Acorda Therapeutics position as of Q2 2014 after selling out during the quarter.
WMS Partners sold 44 Acorda Therapeutics shares in Q2 2014, an estimated $202K.
WMS Partners first reported a position in Acorda Therapeutics in Q1 2014 and held it in 1 quarter.
WMS Partners's Acorda Therapeutics position peaked at $202K in Q1 2014.
162 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2014.

Based on WMS Partners's 13F filing for Q2 2014, filed 11 Aug 2014.